Mission Boost Grants
High-risk/high-reward grants for previous ÁñÁ«ÊÓƵ grantees
Areas Reviewed
- Stage I: Preclinical or clinical research of a new drug, device, or procedure with near-term benefits in cancer patients
- Stage II: Clinical testing of the new drug, device, or procedure
Peer Review Committee Members
Chair, Kenneth Tsai, MD, PhD, H. Lee Moffit Cancer Center and Research Institute
Co-Chair, Analisa DiFeo, PhD, University of Michigan
Community Research Partner, Bernadette Muscat
Swarnali Acharyya, PhD, Columbia University
Joaquina Baranda, MD, University of Kansas Medical Center
Sandra Demaria, MD, Cornell University
Sheri Holmen, PhD, University of Utah
Amy Johnson, PhD, Vincerx Pharma
Binfeng Lu, PhD, Hackensack Meridian Health
Jun Luo, PhD, Johns Hopkins University
Scott Oakes, MD, University of Chicago
Ruth O¡¯Regan, MD, University of Rochester
Greg Palmer, PhD, Duke University
Darren Roblyer, PhD, Boston University
Simpa Salami, MD, MPH, University of Michigan
Natalie Serkova, PhD, University of Colorado